Late Thursday Elevation Oncology Priced Its Public Offering Of 17.81M Shares, Pre-funded Warrants To Purchase Up To 4.44M Shares, And Accompanying Warrants At A Combined Offering Price Of $2.25 For Gross Proceeds Of Approximately $50M
Portfolio Pulse from Benzinga Newsdesk
Elevation Oncology has priced its public offering of 17.81 million shares, pre-funded warrants to purchase up to 4.44 million shares, and accompanying warrants at a combined offering price of $2.25, raising approximately $50 million.
June 09, 2023 | 8:28 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Elevation Oncology's public offering of 17.81M shares and warrants priced at $2.25, raising $50M in gross proceeds.
Elevation Oncology's public offering is expected to raise $50 million, which will provide the company with additional capital for growth and development. However, the short-term impact on the stock price is uncertain, as the market may react positively to the capital infusion or negatively to the dilution of shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100